DHR Danaher Corporation
$232.00▼ -0.42%
Healthcare
Other
After hours
$232.00▲ +0.00%
Oct 27, 4:10 PM ET
Volume 2.50M
Avg Volume (10D) 5.49M
Key Metrics & Fundamentals
Market Cap
$163.09B
P/E Ratio
38.4
Div Yield
0.69%
52W Range
160.93 - 242.80
% vs 50 MA
6.75%
% vs 200 MA
15.33%
RSI-14
60.6
MACD Histogram
+0.4700
Beta (1Y vs SPY)
0.45
Free Cash Flow
$1.63B
Gross Rev
$6.55B
Gross Profit
$3.84B
EBITDA
$2.00B
COGS
$2.72B
Operating Exp
$2.59B
Operating Income
$1.25B
EBIT
$1.25B
Pretax Income
$1.13B
Net Income
$1.24B
EPS (Diluted)
1.75
Price & Volume History
Loading chart…
Recent News

1 safe-and-steady stock with solid fundamentals and 2 we brush off
StockStory · Oct 27, 2026 2:14 PM ET

Danaher (DHR) Upgraded to Buy: Here's Why
Zacks · Oct 27, 2026 11:00 AM ET

Avantor appoints new Chief Information Officer
PR Newswire · Oct 26, 2026 8:05 AM ET
Rothschild & Co Redburn Adjusts Price Target on Danaher to $220 From $205
MT Newswires · Oct 26, 2026 6:30 AM ET

Should Illumina Stock Holders Look At Thermo Fisher Instead?
Trefis · Oct 23, 2026 1:36 PM ET

Is Abbott Stock About To Rebound?
Trefis · Oct 23, 2026 9:12 AM ET
HSBC Adjusts Price Target on Danaher to $260 From $250
MT Newswires · Oct 23, 2026 7:36 AM ET

What Does Danaher (DHR) FDA Clearance For AI AFib Detection Mean Now?
Simply Wall St. · Oct 22, 2026 4:13 PM ET

LH vs. DHR: Which Stock Is the Better Value Option?
Zacks · Oct 22, 2026 10:40 AM ET
JPMorgan Adjusts Danaher Price Target to $270 From $250
MT Newswires · Oct 22, 2026 8:59 AM ET
Financial Overview - Income Statement
Quarterly
Sep 2026
See DHR's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.